Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis.
Saved in:
| Title: | Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis. |
|---|---|
| Authors: | Alasadi Y; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia JC; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arani N; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Page V; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Geng Y; Research Medical Library, The University of Texas MD Anderson Cancer, Houston, TX, USA., Andersen CR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tchakarov A; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center McGovern Medical School, Houston, TX, USA., Kitchlu A; Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada., Mamlouk O; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abudayyeh A; Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Clinical kidney journal [Clin Kidney J] 2025 Nov 29; Vol. 19 (1), pp. sfaf373. Date of Electronic Publication: 2025 Nov 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
